Author/Authors :
Sugawara، نويسنده , , Isamu and Masunaga، نويسنده , , Atsuko and Itoyama، نويسنده , , Shinji and Sumizawa، نويسنده , , Tomoyuki and Akiyama، نويسنده , , Shinichi and Yamashita، نويسنده , , Tomoyuki، نويسنده ,
Abstract :
It was found that the mechanism of anti-cancer drug resistance in anaplastic carcinoma of the thyroid was not explicable only in terms of expression of mdr1 and its gene product, P-glycoprotein. The multidrug resistance-associated protein (MRP), another member of the mdr gene family, may be involved in anti-cancer drug resistance of this carcinoma. The MRP expression was examined immunohistochemically in 8 cell lines and 73 thyroid cancer tissues; its frequency in anaplastic carcinoma (52%) was significantly higher than that in other thyroid cancer types.
Keywords :
Multidrug resistance-associated protein , immunohistochemistry , Anaplastic carcinoma , Thyroid
